
FDA Launches New “One-Day Inspectional Assessment” Program: What Industry Should Know
The FDA has announced a new “One-Day Inspectional Assessment” pilot program aimed at increasing oversight efficiency through rapid, targeted inspections.
Available 24/7 for Urgent On-Site or Virtual Consulting
Ensure your facility passes FDA inspections with confidence. Our experienced team provides comprehensive preparation, documentation review, and on-site support.
Don’t wait until the last minute. Our proactive approach ensures your facility is always inspection-ready.
From preparation to post-inspection support, we provide end-to-end solutions to ensure your facility meets all FDA requirements and maintains compliance.
Comprehensive facility audits, documentation review, and gap analysis to ensure complete readiness.
Expert consultants present during inspections to provide guidance and ensure smooth interactions with FDA officials.
Corrective and Preventive Action plan development for addressing inspection findings and preventing recurrence.
Staff training on FDA regulations, GMP compliance, and inspection preparedness for your entire team.
Design and implementation of robust documentation systems that meet FDA requirements and best practices.
Round-the-clock support for urgent compliance questions and emergency inspection notifications.
Every facility is unique. We provide tailored consulting services to address your specific compliance challenges and regulatory requirements.
With over 15 years of experience in FDA regulatory compliance, our team of former FDA inspectors and industry experts has helped hundreds of facilities successfully navigate complex regulatory requirements.
We understand the challenges you face because we’ve been there. Our practical, results-driven approach ensures your facility not only passes inspections but maintains ongoing compliance excellence.
Our team brings decades of combined experience from both regulatory and industry perspectives.
Facilities Served
Success Rate
Years Experience
Support Available

The FDA has announced a new “One-Day Inspectional Assessment” pilot program aimed at increasing oversight efficiency through rapid, targeted inspections.

Analyzing regulatory enforcement actions provides a roadmap for maintaining a compliant manufacturing environment. This guide explores the most critical FDA Warning Letters Lessons from recent years, focusing on data integrity failures, inadequate CAPA systems, and poor management oversight. Learn how to transform these industry failures into a robust readiness strategy that safeguards your facility from similar enforcement actions.

Maintaining accurate records is the primary requirement for cGMP compliance. However, many firms struggle with systemic paperwork errors. This guide analyzes the most frequent Documentation Failures FDA investigators uncover during audits, ranging from missing signatures to backdated entries. Learn how to identify these gaps through gap analysis and protect your facility from regulatory enforcement and 483 observations.

Navigating an agency audit requires a deep understanding of how investigators evaluate your data. This guide explores the critical elements of Laboratory Records FDA scrutiny, focusing on raw data, audit trails, and ALCOA+ principles. Discover how to identify gaps in your documentation, manage forensic audits, and protect your facility from Warning Letters through proactive laboratory record management.

Regulatory experts agree that proactive identification of compliance weaknesses is the only way to safeguard a life sciences facility. This guide explains how Gap Analysis Prevents FDA Enforcement by pinpointing systemic vulnerabilities before investigators arrive. Explore the methods for auditing your Quality Management System, securing data integrity, and building a robust defense against 483 observations.

Contract testing laboratories are essential partners in the pharmaceutical supply chain. However, they frequently face heavy regulatory scrutiny. This guide analyzes why Contract Testing Laboratories Receive FDA Warning Letters, focusing on data integrity failures and inadequate quality oversight. Learn how labs can identify compliance gaps and protect their clients through rigorous adherence to cGMP standards and forensic audit readiness.
Don’t face your next FDA inspection alone. Contact our experts today for a confidential consultation and ensure your facility is ready.
Your trusted partner for FDA compliance and inspection readiness. With former ex-FDA’ers on our team, we provide the expertise and confidence you need to succeed.